Anchyra Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Anchyra Partners's PFE Position: Q3 2026 in Review
Anchyra Partners increased its Pfizer (PFE) stake by 1.3% in Q3 2026, buying an estimated $3.19K and bringing the position to 9,477 shares worth $270K. The position accounts for 0.06% of the portfolio, ranked #303.
Anchyra Partners first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. The position peaked at $334K in Q1 2026. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Anchyra Partners held 9,477 shares of Pfizer worth $270K as of Q3 2026.
- Anchyra Partners bought 120 Pfizer shares in Q3 2026, an estimated $3.19K.
- Pfizer made up 0.06% of Anchyra Partners's portfolio in Q3 2026, its #303 holding.
- Anchyra Partners first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
- Anchyra Partners's Pfizer position peaked at $334K in Q1 2026.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.